Tag: Novartis
Novartis to acquire MorphoSys for US$2.9B to bolster oncology portfolio
by Editor | Feb 7, 2024 | Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
SWITZERLAND – Novatis a pharmaceutical corporation based in Switzerland has revealed that...
Read MoreNovartis to start pharmaceutical production of Pluvicto in the US
by Editor | Jan 12, 2024 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
SWITZERLAND – Novartis plans to start commercial production of Pluvicto at its large-scale,...
Read MoreNovartis settles long-running patent dispute, resolving Daiichi Sankyo lawsuit for US$180 million
by Editor | Dec 10, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
USA – Novartis has reached a settlement, paying US$180 million to Daiichi Sankyo’s Plexxikon...
Read MoreFDA approves Novartis’ Fabhalta, a groundbreaking oral monotherapy for rare blood disease treatment
by Editor | Dec 7, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
SWITZERLAND — The U.S. Food and Drug Administration (FDA) has approved Novartis’ oral drug...
Read MoreEmirates Oncology Society, Novartis ink breast cancer care deal
by Editor | Nov 4, 2023 | AFRICAN & MIDDLE EAST NEWS, Hospitals, LATEST NEWS, NGOs, Associations & Development Partners | 0
UAE – Novartis and the Emirates Oncology Society (EOS) have joined forces to launch a new...
Read MoreNovartis and Alfa Labs unite to increase access to cardiovascular care
by Editor | Oct 4, 2023 | AFRICAN & MIDDLE EAST NEWS, LATEST NEWS, Mergers, Investments & Funding | 0
EGYPT – Novartis Pharma S.A.E. (Novartis Egypt) and Alfa Labs have joined forces to enhance the...
Read MoreNovartis shuffles leadership as international markets leader departs
by Editor | Sep 10, 2023 | LATEST NEWS, People News, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
SWITZERLAND — Novartis, in the midst of a major organizational overhaul, is facing a significant...
Read MoreNovartis advances spin-off of Sandoz, eyes growth in generics and biosimilars
by Editor | Sep 10, 2023 | Mergers, Investments & Funding, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
SWITZERLAND — In a significant strategic move, Novartis has reaffirmed its commitment to the...
Read MoreLong-term efficacy of Novartis’ siRNA therapy in LDL-C reduction unveiled in three-year follow-up trial
by Editor | Aug 29, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
SWITZERLAND —In a significant stride towards combatting cardiovascular disease, a recent...
Read MoreNovartis pulls sickle cell drug Adakveo from European market following regulatory reversal
by Editor | Aug 10, 2023 | Government, Regulatory & Policy News, LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
EUROPE — A regulatory upheaval has led pharmaceutical giant Novartis to withdraw its sickle cell...
Read MoreNovartis acquires DTx Pharma for US$500 million to expand neuroscience pipeline
by Editor | Jul 18, 2023 | LATEST NEWS, Mergers, Investments & Funding, WORLD NEWS | 0
SWITZERLAND — Novartis, the Swiss pharmaceutical company has acquired DTx Pharma, a preclinical...
Read MoreSamsung Biologics expands partnerships with Novartis and Pfizer, revolutionizing biologics manufacturing
by Editor | Jul 14, 2023 | LATEST NEWS, Pharmaceuticals & Manufacturing, WORLD NEWS | 0
SOUTH KOREA — In an exciting development for the biologics manufacturing sector, Samsung...
Read More